Matthew Mc Manus is President - Diag & Spatial Bio of BIO-TECHNE Corp. Currently has a direct ownership of 4,735 shares of TECH, which is worth approximately $263,408. The most recent transaction as insider was on Aug 15, 2025, when has been sold 880 shares (Common Stock) at a price of $53.6 per share, resulting in proceeds of $47,168. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.74K
59.0% 3M change
n/a 12M change
Total Value Held $263,408

Matthew McManus Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 15 2025
SELL
Payment of exercise price or tax liability
$47,168 $53.6 p/Share
880 Reduced 15.67%
4,735 Common Stock
Aug 15 2025
BUY
Exercise of conversion of derivative security
-
2,637 Added 31.96%
5,615 Common Stock
Feb 01 2025
SELL
Payment of exercise price or tax liability
$120,769 $73.55 p/Share
1,642 Reduced 35.54%
2,978 Common Stock
Feb 01 2025
BUY
Exercise of conversion of derivative security
-
4,620 Added 50.0%
4,620 Common Stock

Also insider at

AZTA
Azenta, Inc. Healthcare
MM

Matthew Mc Manus

President - Diag & Spatial Bio
Chelmsford, MA

Track Institutional and Insider Activities on TECH

Follow BIO-TECHNE Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TECH shares.

Notify only if

Insider Trading

Get notified when an Bio Techne Corp insider buys or sells TECH shares.

Notify only if

News

Receive news related to BIO-TECHNE Corp

Track Activities on TECH